Literature DB >> 32611725

C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages.

Xaria X Li1, Richard J Clark1, Trent M Woodruff2.   

Abstract

The complement activation fragment C5a is a potent proinflammatory mediator that is increasingly recognized as an immune modulator. C5a acts through two C5a receptors, C5aR1 (C5aR, CD88) and C5aR2 (C5L2, GPR77), to powerfully modify multiple aspects of immune cell function. Although C5aR1 is generally acknowledged to be proinflammatory and immune-activating, the potential roles played by C5aR2 remain poorly defined. Despite studies demonstrating C5aR2 can modulate C5aR1 in human cells, it is not yet known whether C5aR2 functionality is limited to, or requires, C5aR1 activation or influences immune cells more broadly. The present study, therefore, aimed to characterize the roles of C5aR2 on the signaling and function of primary human monocyte-derived macrophages, using a C5aR2 agonist (Ac-RHYPYWR-OH; P32) to selectively activate the receptor. We found that although C5aR2 activation with P32 by itself was devoid of any detectable MAPK signaling activities, C5aR2 agonism significantly dampened C5aR1-, C3aR-, and chemokine-like receptor 1 (CMKLR1)-mediated ERK signaling and altered intracellular calcium mobilization mediated by these receptors. Functionally, selective C5aR2 activation also downregulated cytokine production triggered by various TLRs (TLR2, TLR3, TLR4, and TLR7), C-type lectin receptors (Dectin-1, Dectin-2, and Mincle), and the cytosolic DNA sensor stimulator of IFN genes (STING). Surprisingly, activity at the C-type lectin receptors was particularly powerful, with C5aR2 activation reducing Mincle-mediated IL-6 and TNF-α generation by 80-90%. In sum, this study demonstrates that C5aR2 possesses pleiotropic functions in primary human macrophages, highlighting the role of C5aR2 as a powerful regulator of innate immune function.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32611725     DOI: 10.4049/jimmunol.2000407

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  COVID-19: Complement, Coagulation, and Collateral Damage.

Authors:  Martin W Lo; Claudia Kemper; Trent M Woodruff
Journal:  J Immunol       Date:  2020-07-22       Impact factor: 5.422

Review 2.  Emerging roles of the complement system in host-pathogen interactions.

Authors:  Sanjaya K Sahu; Devesha H Kulkarni; Ayse N Ozanturk; Lina Ma; Hrishikesh S Kulkarni
Journal:  Trends Microbiol       Date:  2021-09-29       Impact factor: 17.079

3.  Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors.

Authors:  Shubhi Pandey; Punita Kumari; Mithu Baidya; Ryoji Kise; Yubo Cao; Hemlata Dwivedi-Agnihotri; Ramanuj Banerjee; Xaria X Li; Cedric S Cui; John D Lee; Kouki Kawakami; Jagannath Maharana; Ashutosh Ranjan; Madhu Chaturvedi; Gagan Deep Jhingan; Stéphane A Laporte; Trent M Woodruff; Asuka Inoue; Arun K Shukla
Journal:  Mol Cell       Date:  2021-09-27       Impact factor: 19.328

4.  The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.

Authors:  Trent M Woodruff; Arun K Shukla
Journal:  Trends Immunol       Date:  2020-09-23       Impact factor: 16.687

Review 5.  Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.

Authors:  Marion Ort; Jasper Dingemanse; John van den Anker; Priska Kaufmann
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

6.  The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist.

Authors:  Xaria X Li; Vinod Kumar; Richard J Clark; John D Lee; Trent M Woodruff
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

7.  An Integrated Analysis of C5AR2 Related to Malignant Properties and Immune Infiltration of Breast Cancer.

Authors:  Yumeng Zhu; Xiaochao Wang; Yanqing Xu; Lu Chen; Peipei Ding; Jianfeng Chen; Weiguo Hu
Journal:  Front Oncol       Date:  2021-09-14       Impact factor: 6.244

8.  Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.

Authors:  Klebea Carvalho; Nicole D Schartz; Gabriela Balderrama-Gutierrez; Heidi Y Liang; Shu-Hui Chu; Purnika Selvan; Angela Gomez-Arboledas; Tiffany J Petrisko; Maria I Fonseca; Ali Mortazavi; Andrea J Tenner
Journal:  J Neuroinflammation       Date:  2022-07-11       Impact factor: 9.587

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.